No Prescription |
 |
 | ||
|
Vitamax Vitamin C |
|
| ||
No Prescription » Prescription Drugs 17 » Vitamax Vitamin C May reduce the severity and duration of colds may assist in maintaining a healthy immune system and assisting wound healing via its role in collagen production. How it worksVitamin C plays an important role in the manufacture of collagen the major protein in the body. Collagen is a structural protein found in tissue cartilage and tendons and it helps to support blood vessels. Due to its structural role in collagen synthesis Vitamin C is necessary for wound repair healthy gums minimising of bruising and helping to reduce the risk of infection. They do not containAdded yeast starch gluten or artificial preservatives. DosageAdults 1 tablet 2 times daily with food or as professionally prescribed. Children (age 4 to 12) ¢ tablet 2 times daily with food or as professionally prescribed. Children (under 4) Not recommended for children under 4. Buy Vitamax Vitamin C and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Vitamax Vitamin C: Product Type: Prescription Drugs 17 Vitamax Vitamin C (Product Origin: New Zealand) Vitamax Vitamin C Vitamax Vitamin C 500mg Vitamax Vitamin C Vitamax Vitamin C
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
